SLCO2A1

solute carrier organic anion transporter family member 2A1, the group of Solute carrier organic anion transporter family

Basic information

Region (hg38): 3:133932701-134052184

Previous symbols: [ "SLC21A2", "MATR1" ]

Links

ENSG00000174640NCBI:6578OMIM:601460HGNC:10955Uniprot:Q92959AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (Strong), mode of inheritance: AR
  • hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (Definitive), mode of inheritance: AR
  • pachydermoperiostosis (Supportive), mode of inheritance: AR
  • chronic enteropathy associated with SLCO2A1 gene (Supportive), mode of inheritance: AR
  • hypertrophic osteoarthropathy, primary, autosomal dominant (Definitive), mode of inheritance: AD
  • hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (Strong), mode of inheritance: AR
  • hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hypertrophic osteoarthropathy, primary, autosomal dominant; PHOAR2-enteropathy syndromeAD/ARMusculoskeletalFor both dominant and recessive forms, medical management (eg, with etoricoxib) has been shown to be clinically beneficial related to manifestations affecting multiple organ systems (eg, joint swelling, skin manifestations)Dermatologic; Gastrointestinal; Musculoskeletal16283874; 20889364; 22553128; 22331663; 22197487; 28425581; 33852188
Heterozygotes may show mild manifestations

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLCO2A1 gene.

  • not_provided (230 variants)
  • Inborn_genetic_diseases (57 variants)
  • Hypertrophic_osteoarthropathy,_primary,_autosomal_recessive,_2 (56 variants)
  • SLCO2A1-related_disorder (13 variants)
  • Hypertrophic_osteoarthropathy,_primary,_autosomal_dominant (8 variants)
  • not_specified (1 variants)
  • Pachydermoperiostosis_syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLCO2A1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005630.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
65
clinvar
10
clinvar
76
missense
10
clinvar
8
clinvar
102
clinvar
18
clinvar
4
clinvar
142
nonsense
9
clinvar
5
clinvar
14
start loss
0
frameshift
10
clinvar
5
clinvar
15
splice donor/acceptor (+/-2bp)
6
clinvar
3
clinvar
1
clinvar
10
Total 35 21 104 83 14

Highest pathogenic variant AF is 0.0000770128

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLCO2A1protein_codingprotein_codingENST00000310926 14119489
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.28e-130.3911256750731257480.000290
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5183393670.9240.00002024138
Missense in Polyphen147164.690.892571884
Synonymous1.081361530.8890.000008861322
Loss of Function1.322432.10.7490.00000177339

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001320.00132
Ashkenazi Jewish0.0001020.0000992
East Asian0.0009840.000979
Finnish0.00009240.0000924
European (Non-Finnish)0.0002050.000202
Middle Eastern0.0009840.000979
South Asian0.0001660.000163
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: May mediate the release of newly synthesized prostaglandins from cells, the transepithelial transport of prostaglandins, and the clearance of prostaglandins from the circulation. Transports PGD2, as well as PGE1, PGE2 and PGF2A.;
Pathway
Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules;Prostaglandin formation from arachidonate;Transport of organic anions (Consensus)

Recessive Scores

pRec
0.176

Intolerance Scores

loftool
0.891
rvis_EVS
0.27
rvis_percentile_EVS
70.69

Haploinsufficiency Scores

pHI
0.135
hipred
N
hipred_score
0.334
ghis
0.453

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.181

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slco2a1
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; renal/urinary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
lipid transport;prostaglandin transport;sodium-independent organic anion transport;transmembrane transport
Cellular component
plasma membrane;integral component of plasma membrane;membrane
Molecular function
lipid transporter activity;prostaglandin transmembrane transporter activity;sodium-independent organic anion transmembrane transporter activity